Big-deal Gilead rheumatoid arthritis drug rejected by FDA
August 19, 2020 at 11:28 AM EDT
Filgotinib was the early centerpiece of Gilead's $5.1 billion expanded collaboration with Belgium's Galapagos NV.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.